Home » Topics » Regulatory

Regulatory
RSS

Intravenous formulation of Protonix approved by FDA for GERD

March 29, 2001

Enrollment closed in Atrix's phase III trial with four-month Leuprogel

March 29, 2001

Cyamemazine reported to successfully substitute for benzodiazepines

March 27, 2001

Pharmaceutical compositions for obstructive airways disorders claimed by AstraZeneca

March 27, 2001

Expanded use of Visudyne approved in E.U.

March 27, 2001

Schering-Plough receives notification of priority review status for PEG-Intron/Rebetol sBLA

March 27, 2001

Roche seeks FDA approval for Xenical as adjunct in type 2 diabetes

March 23, 2001

Two new antiglaucoma drugs approved by FDA

March 19, 2001

Abbott and NaPro BioTherapeutics file ANDA for paclitaxel

March 19, 2001

New doses of Kadian approved in U.S.

March 15, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...